{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:25:29Z","timestamp":1783571129231,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2007,12,21]],"date-time":"2007-12-21T00:00:00Z","timestamp":1198195200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1007\/s00198-007-0536-4","type":"journal-article","created":{"date-parts":[[2007,12,20]],"date-time":"2007-12-20T07:33:47Z","timestamp":1198136027000},"page":"1147-1152","source":"Crossref","is-referenced-by-count":16,"title":["A C >T polymorphism located at position \u22121 of the Kozak sequence of CD40 gene is associated with low bone mass in Spanish postmenopausal women"],"prefix":"10.1007","volume":"19","author":[{"given":"B.","family":"Pineda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Laporta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hermenegildo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Garc\u00eda-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,12,21]]},"reference":[{"key":"536_CR1","first-page":"159","volume-title":"Selective estrogen receptor modulators: a new brand of multitarget drugs","author":"MA Garcia-Perez","year":"2006","unstructured":"Garcia-Perez MA (2006) Physiological regulation of bone metabolism and estrogen agonism. In: Cano A, Calaf i Alsina J, Due\u00f1as-D\u00edez JL (eds) Selective estrogen receptor modulators: a new brand of multitarget drugs. Springer, Berlin, pp 159\u2013184"},{"key":"536_CR2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"DL Lacey","year":"1998","unstructured":"Lacey DL, Timms E, Tan HL et al (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165\u2013176","journal-title":"Cell"},{"key":"536_CR3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","volume":"397","author":"YY Kong","year":"1999","unstructured":"Kong YY, Yoshida H, Sarosi I et al (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315\u2013323","journal-title":"Nature"},{"key":"536_CR4","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","volume":"13","author":"WC Dougall","year":"1999","unstructured":"Dougall WC, Glaccum M, Charrier K et al (1999) RANK is essential for osteoclast and lymph node development. Genes Dev 13:2412\u20132424","journal-title":"Genes Dev"},{"key":"536_CR5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","volume":"89","author":"WS Simonet","year":"1997","unstructured":"Simonet WS, Lacey DL, Dunstan CR et al (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309\u2013319","journal-title":"Cell"},{"key":"536_CR6","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.4049\/jimmunol.166.3.1482","volume":"166","author":"TJ Yun","year":"2001","unstructured":"Yun TJ, Tallquist MD, Aicher A et al (2001) Osteoprotegerin, a crucial regulator of bone metabolism, also regulates B cell development and function. J Immunol 166:1482\u20131491","journal-title":"J Immunol"},{"key":"536_CR7","doi-asserted-by":"crossref","first-page":"13960","DOI":"10.1073\/pnas.251534698","volume":"98","author":"C Roggia","year":"2001","unstructured":"Roggia C, Gao Y, Cenci S et al (2001) Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci U S A 98:13960\u201313965","journal-title":"Proc Natl Acad Sci U S A"},{"key":"536_CR8","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1172\/JCI11066","volume":"106","author":"S Cenci","year":"2000","unstructured":"Cenci S, Weitzmann MN, Roggia C et al (2000) Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest 106:1229\u20131237","journal-title":"J Clin Invest"},{"key":"536_CR9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/36593","volume":"390","author":"DM Anderson","year":"1997","unstructured":"Anderson DM, Maraskovsky E, Billingsley WL et al (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175\u2013179","journal-title":"Nature"},{"key":"536_CR10","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/35046102","volume":"408","author":"H Takayanagi","year":"2000","unstructured":"Takayanagi H, Ogasawara K, Hida S et al (2000) T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 408:600\u2013605","journal-title":"Nature"},{"key":"536_CR11","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1359\/jbmr.2001.16.12.2215","volume":"16","author":"T Sato","year":"2001","unstructured":"Sato T, Shibata T, Ikeda K et al (2001) Generation of bone-resorbing osteoclasts from B220+ cells: its role in accelerated osteoclastogenesis due to estrogen deficiency. J Bone Miner Res 16:2215\u20132221","journal-title":"J Bone Miner Res"},{"key":"536_CR12","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1359\/jbmr.2000.15.7.1321","volume":"15","author":"M Kanematsu","year":"2000","unstructured":"Kanematsu M, Sato T, Takai H et al (2000) Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand\/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency. J Bone Miner Res 15:1321\u20131329","journal-title":"J Bone Miner Res"},{"key":"536_CR13","first-page":"5438","volume":"63","author":"AN Farrugia","year":"2003","unstructured":"Farrugia AN, Atkins GJ, To LB et al (2003) Receptor activator of nuclear factor-kappaB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo. Cancer Res 63:5438\u20135445","journal-title":"Cancer Res"},{"key":"536_CR14","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1182\/blood-2006-07-037994","volume":"109","author":"Y Li","year":"2007","unstructured":"Li Y, Toraldo G, Li A et al (2007) B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood 109:3839\u20133848","journal-title":"Blood"},{"key":"536_CR15","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1073\/pnas.0605715104","volume":"104","author":"E Lopez-Granados","year":"2007","unstructured":"Lopez-Granados E, Temmerman ST, Wu L et al (2007) Osteopenia in X-linked hyper-IgM syndrome reveals a regulatory role for CD40 ligand in osteoclastogenesis. Proc Natl Acad Sci U S A 104:5056\u20135061","journal-title":"Proc Natl Acad Sci U S A"},{"key":"536_CR16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0378-5122(03)00084-7","volume":"45","author":"MA Garcia-Perez","year":"2003","unstructured":"Garcia-Perez MA, Moreno-Mercer J, Tarin JJ et al (2003) Relationship between PTH, sex steroid and bone turnover marker measurements and bone density in recently postmenopausal women. Maturitas 45:67\u201374","journal-title":"Maturitas"},{"key":"536_CR17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00223-003-0054-0","volume":"74","author":"MA Garcia-Perez","year":"2004","unstructured":"Garcia-Perez MA, Moreno-Mercer J, Tarin JJ et al (2004) Bone turnover markers and PTH levels in surgical versus natural menopause. Calcif Tissue Int 74:143\u2013149","journal-title":"Calcif Tissue Int"},{"key":"536_CR18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0092-8674(86)90762-2","volume":"44","author":"M Kozak","year":"1986","unstructured":"Kozak M (1986) Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44:283\u2013292","journal-title":"Cell"},{"key":"536_CR19","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1210\/en.2004-1617","volume":"146","author":"EM Jacobson","year":"2005","unstructured":"Jacobson EM, Concepcion E, Oashi T et al (2005) A Graves\u2019 disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology. Endocrinology 146:2684\u20132691","journal-title":"Endocrinology"},{"key":"536_CR20","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1128\/IAI.71.3.1209-1216.2003","volume":"71","author":"LW Schrum","year":"2003","unstructured":"Schrum LW, Marriott I, Butler BR et al (2003) Functional CD40 expression induced following bacterial infection of mouse and human osteoblasts. Infect Immun 71:1209\u20131216","journal-title":"Infect Immun"},{"key":"536_CR21","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1210\/en.2002-221136","volume":"144","author":"SS Ahuja","year":"2003","unstructured":"Ahuja SS, Zhao S, Bellido T et al (2003) CD40 ligand blocks apoptosis induced by tumor necrosis factor alpha, glucocorticoids, and etoposide in osteoblasts and the osteocyte-like cell line murine long bone osteocyte-Y4. Endocrinology 144:1761\u20131769","journal-title":"Endocrinology"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-007-0536-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-007-0536-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-007-0536-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T15:00:54Z","timestamp":1558623654000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-007-0536-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,21]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["536"],"URL":"https:\/\/doi.org\/10.1007\/s00198-007-0536-4","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,21]]}}}